Author

Benjamin M. Larimer

University of Alabama at BirminghamORCID 0000-0002-1288-7206Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein design· 1 Research Focus:protein folding & dynamics· 1 Assay:protein sequence· 1 Assay:proteomics· 1

Frequent Co-Authors

Lucinda A. HalliD· 2 shared Amber Jackson· 1 shared Avraneel PauliD· 1 shared Jasmine Watts· 1 shared John Bart RoseiD· 1 shared Logan Mavar· 1 shared Luke RathbuniD· 1 shared Michael NiederweisiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Lucinda A. HallORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintJun 16, 2026

Improved Calreticulin Nanobody by Framework Engineering

Logan Mavar, Mikhail Pavlenok, Avraneel Paul…·Michael Niederweis

The paper improves a calreticulin-specific nanobody by framework engineering, resulting in higher yield, solubility, and binding affinity.

DOI 10.64898/2026.06.11.731675

protein sequenceexperimental assay

𝕏 PostBluesky

BioengineeringbioRxivPreprintMay 14, 2025

Generation of a Synthetic Single Domain Antibody Library for Radiopharmaceutical Ligand Discovery

Lucinda A. Hall, Rachael E. Guenter, Rodrigo Queiroz…·Benjamin M. Larimer

This paper develops a synthetic nanobody library for radiopharmaceutical ligand discovery, demonstrating its utility through PET imaging of a calreticulin-binding nanobody.

1 citation

𝕏 PostBluesky